ImmunityBio COVID-19 vaccine (2nd generation adenoviral platform)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ImmunityBio COVID-19 vaccine (2nd generation adenoviral platform), covering 2024-11-15 to 2024-11-15. Get the full timeline:
Most recent: Clinical Trial Update: COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults [Phase 1]